Venus Ginés selected to serve as the Chair of the National Steering Committee for Promotores (as) de Salud/Community Health Workers (P/CHW) by U.S. Dept. of Health and Human Services’ Office of Minority Health (OMH)
(May 20, 2011) Houston, TX- Día de la Mujer Latina CEO/Founder, Venus Ginés has been honored to have been selected to serve as the Chair of the National Steering Committee for Promotores (as) de Salud/Community Health Workers (P/CHW). The Office of Minority Health in partnership with other US Department of Health and Human Services’ agencies is charged with developing and managing the National Steering Committee for Promotores de Salud/CHWs. View the entire press release here.
TLSF’s Deborah Vollmer Dahlke Appointed to Susan G. Komen for the Cure Advocates in Science
(October 25, 2010) – Texas Life Science Foundation’s (TLSF) Director of Clinical Trials, Deborah Vollmer Dahlke was appointed to serve as a member of the prestigious Susan G. Komen for the Cure Advocates in Science. Komen’s Advocates in Science program involves advocates in a variety of scientific activities to ensure that their perspectives are integrated into the scientific dialog. Vollmer Dahlke also serves as a research advocate for the American College of Surgeons Oncology Group (ACOSOG) working with the ACOSOG breast cancer group to review and provide advocate input into breast cancer trial proposals under consideration by the group.
Working with www.breastcancertrials.org, a nationally recognized patient matching system for breast cancer patients, Vollmer Dahlke has helped increase the number of Texas breast cancer trials and research centers available for online matching and referral. In her work at TLSF, she developed the patent-pending Navi4Health clinical trial case management system to support patient navigators and Promotoras de Salud in their work with cancer patients. View the entire press release here.
TLSF’s Navi4Health at the 6th Annual Texas Breast Cancer Collaborative Meeting
(October 25, 2010) – Texas Life Science Foundation’s (TLSF) Navi4Health clinical trial and care case management is the subject of a peer-reviewed poster session at the 6th Annual Breast Health Summit in Houston, October 27-28. The poster, presented in the Education and Outreach section, provides data from the recently completed Dia de la Mujer Latina (DML) Promotora de Salud training project which was supported through a grant from Blue Cross Blue Shield of Texas. TLSF’s Navi4Health was selected by DML to provide case management for over 1200 Latina participants in the project. Participant demographics, barriers to care, cancer screening and survivorship information were captured by the Promotoras using Navi4Health’s online systems. Additionally the Promotora time and resources allocated to navigate participants to care continues to be tracked using Navi4Health. DML provided training and Texas-state certification to 160 Promotores/as de Salud and Community Health Workers in this project. View the entire press release here. View the poster here.
TLSF’s Navi4Health Clinical Trial Case Management in The Monitor
(August 15, 2010) – Texas Life Science Foundation’s (TLSF) Navi4Health clinical trial and care case management solution is featured in the August 2010 issue of The Monitor: The Global Voice of Clinical Research Professionals. The peer reviewed article, entitled “From Policy to Practice: Understanding and Enhancing Minority Participation in Clinical Trials,” describes Navi4Health along with other programs that address the problems associated with recruiting and retaining underrepresented populations in clinical trials. View the entire press release here.
Richard Beswick Joins Texas Life Science Foundation Board
(March 2, 2010) – Richard Beswick, Ph. D, MBA, Director of Research for Scott & White Memorial Hospital in Temple, Texas, has joined the board of directors for the Texas Life Science Foundation (TLSF).
Prior to joining Scott & White, Dr. Beswick served as Medical Director for Nephrology and Oncology with Roche Pharmaceuticals. At Roche, Dr. Beswick was in charge of development of novel nephrology and oncology agents for clinical trials from Phase I –IV. Previously, Dr. Beswick worked for Johnson and Johnson/Orthobiotech as New Business Manager, Manager for Clinical Affairs and as Associate Medical Director. Dr. Beswick has developed numerous protocols for academia and the pharmaceutical industry. View the entire press release here.
Texas Life Science Foundation Receives CPRIT Planning Grant Award
(January 27, 2010) – Texas Life Science Foundation (TLSF) is among the first group of grant recipients from the Cancer Prevention and Research Institute of Texas’s (CPRIT) $3 billion in funds for cancer research. TLSF’s grant from CPRIT will support collaboration among Texas cancer clinical trial researchers, patient navigators and cancer advocacy groups in planning for a full CPRIT multi-site grant later this year to create a Texas-wide patient matching and navigation system. Texas has the largest number of cancer clinical trials in the nation, and investments from CPRIT are expected to expand the number and types of clinical trials available to Texas residents. View the entire press release here.